Connect Sign In
ARUP Consult offers expert guidance on laboratory testing for influenza, RSV, and COVID-19, helping clinicians order the right tests at the right time.
ARUP has launched a new assay for the detection and subtyping of influenza A (H5) virus, which will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A (H5N1).
Benjamin Bradley, MD, PhD, compared the H5N1 outbreak to COVID-19, highlighting the preparedness of labs and the CDC’s proactive approach during a media briefing.
ARUP has been awarded a CDC contract for avian influenza A (H5N1) test development, which recognizes our expertise and experience with assay development and our desire to serve public health needs.
ARUP has been working on a bird flu testing solution for more than a year and is prepared to scale up capacity quickly should the need arise.
ARUP experts will present at ASM Microbe 2024 on emerging topics in infectious disease, including parasitology, mycobacterial infections, and more.
Next generation sequencing provides a more rigorous and sensitive method to identify drug-resistant variants of cytomegalovirus, which enables earlier detection and more effective treatment.
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on testing for Lyme disease, diagnosing pneumonia, and evaluating infertility.
ARUP’s new test to detect Candida auris will offer a robust screening tool to help clinical facilities identify patients colonized with the yeast and guide infection prevention measures.
Tickborne diseases such as babesiosis are on the rise in the United States and are primarily transmitted during the summer months when ticks are most active.
